alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › ratio

ratio

5 studies tagged ratio, dated 2017-07-11 to 2025-04-01. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. Differences in Alzheimer's disease blood biomarker stability: Implications for the use of tau/amyloid ratios 2025-04-01
  2. Plasma p-tau217 and neurofilament/p-tau217 ratio in differentiating Alzheimer's disease from syndromes associated with frontotemporal lobar degeneration 2025-01-08
  3. Platelet Amyloid-β Protein Precursor (AβPP) Ratio and Phosphorylated Tau as Promising Indicators for Early Alzheimer's Disease 2020-03-01

Studies

5 studies carry this tag.

Date range

2017 to 2025

Top journals

  • Alzheimer's & dementia : the journal of the Alzheimer's Association 2
  • Current Alzheimer research 1
  • Neurobiology of aging 1
  • The journals of gerontology. Series A, Biological sciences and medical sciences 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Differences in Alzheimer's disease blood biomarker stability: Implications for the use of tau/amyloid ratios

    ✓ Peer-reviewed alzhub usefulness score 48 out of 100. Alzheimer's & dementia : the journal of the Alzheimer's Association 2025-04-01 Biomarkers

    Differences in the stability of Aβ42 and p-tau217 may lead to altered p-tau217/Aβ42 ratio results if samples are not handled properly during the pre-analytical testing phase.

  2. Plasma p-tau217 and neurofilament/p-tau217 ratio in differentiating Alzheimer's disease from syndromes associated with frontotemporal lobar degeneration

    ✓ Peer-reviewed alzhub usefulness score 76 out of 100. Alzheimer's & dementia : the journal of the Alzheimer's Association 2025-01-08 Biomarkers

    Plasma p-tau 217 and the NfL/p-tau 217 ratio are promising non-invasive biomarkers for differentiating AD from FTLD, suggesting their use as a potential alternative to traditional diagnostic methods.

  3. Platelet Amyloid-β Protein Precursor (AβPP) Ratio and Phosphorylated Tau as Promising Indicators for Early Alzheimer's Disease

    ✓ Peer-reviewed alzhub usefulness score 66 out of 100. The journals of gerontology. Series A, Biological sciences and medical sciences 2020-03-01 Biomarkers

    To identify whether platelet amyloid-β protein precursor (AβPP) ratio, phosphorylated-tau (P-tau) 231, P-tau181, and serine 396 and 404 (Ser396/404) phosphorylated tau are potential peripheral indicators for early Alzheimer's disease (AD).

  4. The CSF p-tau181/Aβ42 Ratio Offers a Good Accuracy "In Vivo" in the Differential Diagnosis of Alzheimer's Dementia

    ✓ Peer-reviewed alzhub usefulness score 47 out of 100. Current Alzheimer research 2019-01-01 Biomarkers

    The p-tau181/Aβ42 ratio alone might reliably detect AD pathology in heterogeneous samples of patients suffering from different types of dementia.

  5. CSF/serum albumin ratio in dementias: a cross-sectional study on 1861 patients

    ✓ Peer-reviewed alzhub usefulness score 50 out of 100. Neurobiology of aging 2017-07-11 Biomarkers

    A connection between dementias and blood-brain barrier (BBB) dysfunction has been suggested, but previous studies have yielded conflicting results.

All topic tags with their study counts